- Home
- REKR vs NVCT Comparison
REKR vs NVCT Comparison
Compare REKR & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REKR | NVCT |
|---|---|---|
| Founded | 2017 | 2020 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 216.5M | 220.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | REKR | NVCT |
|---|---|---|
| Price | $0.75 | $8.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $15.33 |
| AVG Volume (30 Days) | ★ 3.1M | 64.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.82 | N/A |
| Revenue Next Year | $22.78 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.62 | $5.55 |
| 52 Week High | $3.42 | $11.52 |
Technical Indicators
Market Signals| Indicator | REKR | NVCT |
|---|---|---|
| Relative Strength Index (RSI) | 17.47 | 59.78 |
| Support Level | $0.79 | $8.12 |
| Resistance Level | $1.01 | $9.23 |
| Average True Range (ATR) | 0.08 | 0.52 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 0.23 | 79.07 |
Price Performance
Historical ComparisonAbout REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.